Detalus Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,990
Closed -$220K 152
2024
Q3
$220K Buy
+1,990
New +$208K 0.07% 139
2024
Q2
Sell
-1,985
Closed -$222K 151
2024
Q1
$222K Buy
+1,985
New +$214K 0.08% 134
2023
Q2
Sell
-2,675
Closed -$202K 150
2023
Q1
$202K Buy
2,675
+3
+0.1% +$226 0.1% 131
2022
Q4
$205K Buy
+2,672
New +$203K 0.1% 123

Other funds holding CAH

Detalus Advisors's CAH Position: Q4 2024 in Review

Detalus Advisors sold out of Cardinal Health (CAH) in Q4 2024, closing a stake of 1,990 shares — an estimated $220K sold.

Detalus Advisors first reported a position in CAH in Q4 2022 and held it in 4 quarters. The position peaked at $222K in Q1 2024. 1,097 funds tracked by Wall St. Rank hold CAH as of Q4 2024.

  • Detalus Advisors reported no remaining Cardinal Health position as of Q4 2024 after selling out during the quarter.
  • Detalus Advisors sold 1,990 Cardinal Health shares in Q4 2024, an estimated $220K.
  • Detalus Advisors first reported a position in Cardinal Health in Q4 2022 and held it in 4 quarters.
  • Detalus Advisors's Cardinal Health position peaked at $222K in Q1 2024.
  • 1,097 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2024.

Based on Detalus Advisors's 13F filing for Q4 2024, filed 6 Feb 2025.